Chronic renovascular hypertension is associated with elevated levels of neutrophil gelatinase-associated lipocalin

Nephrology Dialysis Transplantation

Volumn 27, Issue 11, 2012, Pages 4153-4161

  Eirin, Alfonso ^a   Gloviczki, Monika L ^a   Tang, Hui ^a   Rule, Andrew D ^a   Woollard, John R ^a   Lerman, Amir ^a   Textor, Stephen C ^a   Lerman, Lilach O ^a  

^a MAYO CLINIC   (United States)

Author keywords

cytokines; inflammation; KIM 1; NGAL; renovascular hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; CREATININE; GAMMA INTERFERON; KIDNEY INJURY MOLECULE 1; MACROPHAGE INFLAMMATORY PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 1DELTA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SODIUM; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INFERIOR CAVA VEIN; KIDNEY ARTERY STENOSIS; KIDNEY ISCHEMIA; KIDNEY VEIN; MALE; NEPHRITIS; NEPHROSCLEROSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RENOVASCULAR HYPERTENSION; SODIUM INTAKE; STENOSIS;

ACUTE-PHASE PROTEINS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CYTOKINES; FEMALE; HUMANS; HYPERTENSION, RENOVASCULAR; KIDNEY; LIPOCALINS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; RECEPTORS, VIRUS; RENAL VEINS;

EID: 84869413380     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs370     Document Type: Article

References (45)

1. Preston RA, Epstein M. Ischemic renal disease: an emerging cause of chronic renal failure and end-stage renal disease. J Hypertens 1997; 15:1365-1377. (Pubitemid 28039562)
2. Kalra PA, Guo H, Kausz AT et al. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int 2005; 68:293-301. (Pubitemid 43181388)
3. Matavelli LC, Huang J, Siragy HM. Angiotensin at receptor stimulation inhibits early renal inflammation in renovascular hypertension. Hypertension 2011; 57:308-313.
4. Zhu XY, Chade AR, Krier JD et al. The chemokine monocyte chemoattractant protein-1 contributes to renal dysfunction in swine renovascular hypertension. J Hypertens 2009; 27:2063-2073.
5. Chade AR, Rodriguez-Porcel M, Herrmann J et al. Beneficial effects of antioxidant vitamins on the stenotic kidney. Hypertension 2003; 42:605-612. (Pubitemid 37237361)
6. Chade AR, Rodriguez-Porcel M, Herrmann J et al. Antioxidant intervention blunts renal injury in experimental renovascular disease. J Am Soc Nephrol 2004; 15:958-966. (Pubitemid 38375315)
7. Saeed A, Herlitz H, Nowakowska-Fortuna E et al. Oxidative stress and endothelin-1 in atherosclerotic renal artery stenosis and effects of renal angioplasty. Kidney Blood Press Res 2011; 34:396-403.
8. Cowland JB, Sorensen OE, Sehested M et al. Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-alpha. J Immunol 2003; 171:6630-6639. (Pubitemid 37532095)
9. Mishra J, Dent C, Tarabishi R et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365:1231-1238. (Pubitemid 40469655)
10. Wagener G, Jan M, Kim M et al. Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 2006; 105:485-491. (Pubitemid 44310430)
11. Kumpers P, Hafer C, Lukasz A et al. Serum neutrophil gelatinase- associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury. Crit Care 2010; 14: R9.
12. Hirsch R, Dent C, Pfriem H et al. NGAL is an early predictive bio-marker of contrast-induced nephropathy in children. Pediatr Nephrol 2007; 22:2089-2095. (Pubitemid 350090716)
13. Mishra J, Ma Q, Prada A et al. Identification of neutrophil gelati-nase-associated lipocalin as a novel early urinary biomarker for is-chemic renal injury. J Am Soc Nephrol 2003; 14:2534-2543. (Pubitemid 37169339)
14. Ichimura T, Bonventre JV, Bailly V et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 1998; 273:4135-4142. (Pubitemid 28103282)
15. Liangos O, Tighiouart H, Perianayagam MC et al. Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass. Biomarkers 2009; 14:423-431.
16. Han WK, Waikar SS, Johnson A et al. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int 2008; 73:863-869. (Pubitemid 351398278)
17. Leoncini G, Mussap M, Viazzi F et al. Combined use of urinary neutrophil gelatinase-associated lipocalin (UNGAL) and albumin as markers of early cardiac damage in primary hypertension. Clin Chim Acta 2011; 412:1951-1956.
18. Malyszko J, Bachorzewska-Gajewska H, Malyszko JS et al. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease. Nephrology (Carlton) 2008; 13:153-156. (Pubitemid 351232835)
19. Van Timmeren MM, Van den Heuvel MC, Bailly V et al. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol 2007; 212:209-217. (Pubitemid 46852099)
20. Gloviczki ML, Glockner JF, Lerman LO et al. Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis. Hypertension 2010; 55:961-966.
21. Murphy TP, Cooper CJ, Dworkin LD et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. J Vasc Interv Radiol 2005; 16:1295-1300. (Pubitemid 41463986)
22. Mehta RL, Kellum JA, Shah SV et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31.
23. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604-612.
24. Losito A, Fagugli RM, Zampi I et al. Comparison of target organ damage in renovascular and essential hypertension. Am J Hypertens 1996; 9:1062-1067. (Pubitemid 26383488)
25. Schmidt-Ott KM, Mori K, Li JY et al. Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 2007; 18:407-413. (Pubitemid 46193306)
26. Bolignano D, Coppolino G, Lacquaniti A et al. From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology. Eur J Clin Invest 2010; 40:273-276.
27. Bolignano D, Donato V, Lacquaniti A et al. Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. Cancer Lett 2010; 288:10-16.
28. Haase M, Haase-Fielitz A, Bellomo R et al. Neutrophil gelatinase-associated lipocalin as a marker of acute renal disease. Curr Opin Hematol 2011; 18:11-18.
29. Singer E, Elger A, Elitok S et al. Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes. Kidney Int 2011; 80:405-414.
30. Nickolas TL, O'Rourke MJ, Yang J et al. Sensitivity and specificity of a single emergency department measurement of urinary neutro-phil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 2008; 148:810-819. (Pubitemid 351786928)
31. Mitsnefes MM, Kathman TS, Mishra J et al. Serum neutrophil gela-tinase-associated lipocalin as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol 2007; 22:101-108. (Pubitemid 46138368)
32. Viau A, El Karoui K, Laouari D et al. Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. J Clin Invest 2010; 120:4065-4076.
33. Ko GJ, Grigoryev DN, Linfert D et al. Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition. Am J Physiol Renal Physiol 2010; 298: F1472-F1483.
34. Bolignano D, Basile G, Parisi P et al. Increased plasma neutro-phil gelatinase-associated lipocalin levels predict mortality in elderly patients with chronic heart failure. Rejuvenation Res 2009; 12:7-14.
35. Giaginis C, Zira A, Katsargyris A et al. Clinical implication of plasma neutrophil gelatinase-associated lipocalin (ngal) concentrations in patients with advanced carotid atherosclerosis. Clin Chem Lab Med 2010; 48:1035-1041.
36. Forsblad J, Gottsater A, Persson K et al. Clinical manifestations of atherosclerosis in an elderly population are related to plasma neop-terin, NGAL and endothelin-1, but not to Chlamydia pneumoniae serology. Int Angiol 2002; 21:173-179.
37. Paulsson J, Dadfar E, Held C et al. Activation of peripheral and in vivo transmigrated neutrophils in patients with stable coronary artery disease. Atherosclerosis 2007; 192:328-334. (Pubitemid 46726335)
38. Ramos-Mozo P, Madrigal-Matute J, Vega de Ceniga M et al. Increased plasma levels of NGAL, a marker of neutrophil activation, in patients with abdominal aortic aneurysm. Atherosclerosis 2012; 220:552-556.
39. Falke P, Elneihoum AM, Ohlsson K. Leukocyte activation: relation to cardiovascular mortality after cerebrovascular ischemia. Cerebro-vasc Dis 2000; 10:97-101. (Pubitemid 30107503)
40. Camont L, Chapman MJ, Kontush A. Biological activities of HDL subpopulations and their relevance to cardiovascular disease. Trends Mol Med 2011; 17:594-603.
41. Keddis MT, Garovic VD, Bailey KR et al. Ischaemic nephropathy secondary to atherosclerotic renal artery stenosis: clinical and histo-pathological correlates. Nephrol Dial Transplant 2010; 25:3615-3622.
42. Textor SC, Lerman LO. Inflammatory cell markers as indicators of atherosclerotic renovascular disease. Clin J Am Soc Nephrol 2012; 7:193-195.
43. Truong LD, Farhood A, Tasby J et al. Experimental chronic renal ischemia: morphologic and immunologic studies. Kidney Int 1992; 41:1676-1689.
44. Haller S, Adlakha S, Reed G et al. Platelet activation in patients with atherosclerotic renal artery stenosis undergoing stent revascular-ization. Clin J Am Soc Nephrol 2011; 6:2185-2191.
45. Arena A, Stassi G, Iannello D et al. Both IL-1beta and TNF-alpha regulate NGAL expression in polymorphonuclear granulocytes of chronic hemodialysis patients. Mediators Inflamm 2010; 2010:613937.